Drug details
Rybelsus (semaglutide tablets)
type of Antidiabetics, Glucagon-like Peptide-1 Agonists
Rybelsus (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
This drug may have the following side effects:
- hives,
- nausea,
- rash,
- vomiting,
- fever,
- pale skin,
- lightheadedness,
- shortness of breath,
- confusion,
- chills,
- fast heartbeats,
- stomach pain,
- chest pain,
- blurred vision,
- coughing,
- fatigue,
- nervousness,
- sweating,
- weakness,
- trouble swallowing,
- headaches,
- hoarseness,
- irregular heartbeat,
- seizures,
- anxiety,
- irritability,
- decreased urination,
- hunger,
- nightmares,
- coordination difficulties,
- sudden vision loss,
- sleepiness,
- eye pain or redness,
- neck pain,
- difficulty breathing
- clamminess,
- impatience,
- swelling in your legs, ankles, or feet,
- a lump on the front of the neck,
- upper stomach pain that radiates to your back,
- stomach pain that feels worse after eating,
- floaters in your field of vision,
- gradually worsening vision,
- feeling shaky,
- tingling or numbness in the lips, tongue, or cheeks,
- swelling of your face, tongue or throat, and
The following drugs are related to Rybelsus, either as a replacement or used together:
- Actos (pioglitazone hydrochloride)
- Amaryl Tablets (glimepiride)
- Baqsimi (glucagon nasal powder)
- Brenzavvy (bexagliflozin tablets)
- Invokana (canagliflozin tablets)
- Trulicity (dulaglutide injection, for subcutaneous use)
- Jardiance (empagliflozin tablets)
- Tresiba (insulin degludec injection)
- Januvia (sitagliptin phosphate)
- Tradjenta (linagliptin)
- Saxenda (liraglutide [rdna origin]) injection)
- Ozempic (semaglutide injection)